Matthew R. Plooster - Mar 9, 2023 Form 4 Insider Report for ZEVRA THERAPEUTICS, INC. (ZVRA)

Role: Director
Signature: /s/ Timothy J. Sangiovanni, Attorney-in-Fact for Matthew R. Plooster
Stock symbol: ZVRA
Transactions as of: Mar 9, 2023
Transactions value $: $46,148
Form type: 4
Date filed: 3/13/2023, 07:59 AM
Previous filing: Jun 30, 2022
Next filing: May 8, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ZVRA	Common Stock	Purchase	$46.1K	+11K	+146.67%	$4.20	18.5K	Mar 9, 2023	Direct	F1, F2
holding	ZVRA	Common Stock						69	Mar 9, 2023	By TD Ameritrade Clearing Inc. Custodian FBO Matthew Ryan Plooster Roth IRA, as trustee
holding	ZVRA	Common Stock						1.53K	Mar 9, 2023	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Held jointly with spouse.
F2	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.1166 to $4.26, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Content

Held jointly with spouse.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.1166 to $4.26, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.